Sinopharm Group Co. Ltd. (HKG:1099)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
21.70
+0.72 (3.43%)
Feb 23, 2026, 4:08 PM HKT

Sinopharm Group Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
67,71866,47063,81761,91452,92658,856
Market Cap Growth
5.85%4.16%3.08%16.98%-10.07%-30.29%
Enterprise Value
170,909178,877158,985148,432150,328130,433
Last Close Price
21.7020.4818.8117.6214.3815.48
PE Ratio
8.758.866.406.425.566.90
Forward PE
7.787.015.826.054.936.48
PS Ratio
0.110.110.100.100.080.11
PB Ratio
0.470.490.480.500.430.55
P/TBV Ratio
0.860.890.900.950.841.08
P/FCF Ratio
3.276.203.812.915.965.35
P/OCF Ratio
3.075.413.372.614.634.44
PEG Ratio
1.700.870.580.660.430.43
EV/Sales Ratio
0.270.290.240.240.240.24
EV/EBITDA Ratio
6.748.425.915.305.355.26
EV/EBIT Ratio
8.409.436.475.775.845.75
EV/FCF Ratio
8.2516.689.496.9716.9311.86
Debt / Equity Ratio
0.630.600.610.630.690.76
Debt / EBITDA Ratio
3.793.422.782.602.763.04
Debt / FCF Ratio
4.397.584.853.699.457.40
Net Debt / Equity Ratio
0.340.150.060.100.220.17
Net Debt / EBITDA Ratio
2.270.950.270.450.960.75
Net Debt / FCF Ratio
2.351.880.440.593.041.69
Asset Turnover
-1.511.601.581.611.57
Inventory Turnover
-8.839.068.989.689.28
Quick Ratio
1.071.061.060.991.010.99
Current Ratio
1.351.391.401.361.331.31
Return on Equity (ROE)
-8.44%13.03%13.68%13.78%14.50%
Return on Assets (ROA)
-2.87%3.73%4.06%4.06%4.11%
Return on Invested Capital (ROIC)
7.13%9.74%13.84%14.48%14.19%15.09%
Return on Capital Employed (ROCE)
12.20%12.50%15.70%17.50%18.10%17.80%
Earnings Yield
11.42%11.29%15.63%15.57%17.99%14.50%
FCF Yield
30.60%16.13%26.26%34.39%16.78%18.68%
Dividend Yield
3.67%3.53%5.10%5.26%6.40%5.29%
Payout Ratio
10.73%38.51%28.26%27.45%27.75%25.95%
Buyback Yield / Dilution
0.36%--0.12%0.12%-0.30%-4.70%
Total Shareholder Return
4.02%3.53%4.98%5.38%6.10%0.60%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.